MU1140

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
01220092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
INTRODUCTION The effectiveness of lantibiotics against MDR pathogens and the progression of agents MU1140, NAI-107, NVB302 and… (More)
Is this relevant?
2015
2015
The increasing resistance of bacteria to conventional antimicrobial therapy within both the nosocomial and community environment… (More)
  • figure 1
  • table 1
Is this relevant?
2010
2010
Presented are the pharmacokinetics (PK), exposure-response relationship, and the PK/pharmacodynamic (PD) index predictive of… (More)
Is this relevant?
2010
2010
The degree of MU1140 binding to human serum was measured and the effect of serum on MU1140 pharmacodynamics against Streptococcus… (More)
  • table 1
  • figure 2
  • figure 7
  • table 2
Is this relevant?
2009
2009
This study evaluated the pharmacodynamics of the lantibiotic MU1140 and the ability of selected organisms to develop resistance… (More)
  • figure 1
  • table 1
  • figure 4
Is this relevant?
2009
2009
This study reports the first ever development and validation of a quantification method for a lantibiotic in plasma. This method… (More)
Is this relevant?